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DNA-controlled aggregation of virus like
particles – mimicking a tetherin-like mechanism†
Daniela Serien,ab Christiane Grimm,a Jürgen Liebscher,cd Andreas Herrmanna and
Anna Arbuzova*a
Mimicking cellular processes by functional comparable structures
helps to understand their molecular mechanism. We report on an
oligonucleotide modified with two a-tocopherol anchors mimicking
tetherin, a cellular protein reducing spreading of viruses. The lipophilic
DNA was incorporated into vesicles and virus like particles; their
aggregation was induced by the complement addition.
Nucleic acid is a versatile tool for bionanotechnology:1–3 DNA-
controlled assembly of structures is used to fabricate new
materials and for development of drug delivery systems.4–7
Recently, Chou et al. demonstrated that superstructures (built
through DNA-controlled assembly of colloidal particles) showed
improved accumulation in tumor.5 The conjugation of a nucleic
acid to a hydrophobic anchor allows attaching a molecular
recognition unit to a lipid membrane.8–10 Controlled assembly
of vesicles, nanodiscs, and lipid layers, as well as hybridization-
induced aggregation and fusion of lipid vesicles carrying lipophilic
modifications were reported.11–20
Lipophilic nucleic acids have been used to mimic protein func-
tions, e.g. channels21 and SNARE proteins mediating fusion.13,14,22
Here we suggest using a lipophilic oligonucleotide with two anchors
to mimic tetherin/BST-2/CD317 function. Tetherin is an unusual cell
protein with two membrane anchors – a transmembrane domain
close to the N- and a glycophosphatidylinositol (GPI) anchor at the
C-terminus; it was found on the cell surface and in endosomes.
It is constitutively expressed in many human organs and cell lines,
e.g. in primary T lymphocytes and macrophages.23,24 Tetherin was
found to prevent the release of enveloped viruses from infected
cells.25 Viruses budding from the infected cells expressing tetherin
stay first connected to the cell surface via tetherin, then are taken
up and digested.25,26 Tetherin-based chains of the viruses
attached to the cell surface were observed by immunoelectron
microscopy.27 It was suggested that one of the membrane anchors
of the tetherin stays in the cellular and the other is incorporated
into the viral membrane.25,26 This mechanism is reminiscent of
the mechanism suggested for the aggregation of vesicles induced
by lipophilic DNA (Scheme 1).11,12 A lipophilic DNA with a
hydrophobic anchor at each end binds first to the membrane of
one liposome, as tetherin is incorporated into the plasma
membrane via both N- and C-termini. Addition of the comple-
mentary DNA strand leads to the formation of a rigid DNA double
helix (between the anchors). As the helix becomes oriented
perpendicular to the lipid membrane driven by entropy, one of
the anchors is pulled out of the membrane of the initial vesicle
and might insert into another lipid vesicle.11,12 Indeed, vesicles
aggregated upon addition of lipophilic oligonucleotides of 17–27
nucleic bases (about 2–3 helical turns) modified with cholesteryl
or palmitoyl anchors at both ends and the unmodified comple-
mentary strands.11,12
Scheme 1 A cartoon of tetherin, lipophilic DNA (LiNA), and DNA-induced
aggregation of vesicles pre-incubated with LiNA. Membrane anchors and
the transmembrane domain are shown in cyan. Hydrophilic regions of the
protein and LiNA are shown in green and blue, respectively. Complemen-
tary oligonucleotide is shown in red.
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Using a-tocopherol-modified thymine phosphoamidides,
we have shown that the lipophilic anchor can be incorporated
at any position of an oligonucleotide.28,29 We observed that
a-tocopherol-modified oligonucleotides incorporated spontaneously
into preformed lipid vesicles within seconds, preferentially into
the liquid-disordered phase, without significant perturbation of
the lipid bilayer recommending such lipophilic oligonucleotides
for functionalization of biological membranes.30 Oligonucleotides
modified with a-tocopherol at the terminal phosphate moiety
were recently shown to incorporate spontaneously into cell
membranes.31 Here, we report investigations of a lipophilic
oligonucleotide with two a-tocopherol anchors (L) separated by
18 bases and having additional 5 bases after the lipid anchor
closer to the 30end, TL(dT)18L(dT)5, termed LiNA. Sequences of
the oligonucleotides are provided in Table 1.
The tocopherol anchors were attached to the nucleobase29,32,33
rather than to the terminal phosphate moiety.31,34 The structure of
the anchor is shown in the ESI.† We characterized the LiNAs and
their potential to function in a tetherin-like manner with model
lipid vesicles and then verified it on HIV virus like particles (VLPs).
Lacking regulatory proteins and genetic material, VLPs resemble
morphologically native viruses but are noninfectious.35
We first show using fluorescence microscopy that the LiNA
induced aggregation of model vesicles triggered by hybridization
with a fluorescently labeled complementary strand, 30Rh(dA)20.
Upon mixing of the LiNA, its complement (200 nM each), and
POPC liposomes labeled with the fluorescent lipid analogue
N-NBD-DPPE (400 mM total lipid), micrometer size aggregates
were formed (Fig. 1A). For such high lipid concentrations, the
resulting aggregates became visible even by the naked eye after
a few minutes and precipitated if left undisturbed for several
hours. Apparent co-localization of N-NBD and rhodamine
signals revealed that in the presence of the LiNA 30Rh(dA)20
was accumulated within the aggregates (Fig. 1A and B). If either of
the oligonucleotides was absent, no aggregation was observed: in
the absence of LiNA rhodamine fluorescence was homogeneously
distributed as shown in Fig. S1A, ESI.† Addition of a non-
complementary strand neither induced any aggregation of the
vesicles. The labeled non-complementary strands, 30Rh(dT)20, and
the N-NBD-DPPE labeled vesicles were also distributed homo-
geneously in the presence and in the absence of the LiNA
(Fig. S1B, ESI,† and not shown, respectively). Thus, hybridization
of the LiNA and the complementary strand, 30Rh(dA)20, induced
aggregation of lipid vesicles. We presume that in agreement with
the mechanism suggested before11,12,36 addition of 30Rh(dA)20
led to the formation of a rigid DNA helix between the anchors; as
a consequence one of the a-tocopherol anchors was pulled out of
the vesicle, where the LiNA was incorporated before, and could
insert into another lipid vesicle.
We compared transition temperature of the LiNA with
unlabeled complementary strand, (dA)20, in the absence and
the presence of POPC liposomes. In the absence of liposomes,
dehybridization of LiNA/(dA)20 was measured by following the
increase in absorbance at 270 nm upon heating (Fig. 2A). The
melting temperature, at which half of the hybrids de-hybridized,
was about 38 1C. This melting temperature value indicates that
according to the empirically based prediction algorithm 17 to 18
bases of TL(dT)18L(dT)5 in between the two lipid anchors are
involved in DNA hybridization (e.g. OligoAnalyzer; Integrated
DNA Technologies). For samples with vesicles, LiNA, and (dA)20,
a well-defined sharp transition, corresponding to the disassembly
of the vesicle aggregates, was observed at 39.9  0.2 1C by light
scattering (Fig. 2B).
The width of the transition of 2.3 1C was much smaller than
that of 10 1C observed in the absence of vesicles. Similarly, a
smaller width for the disaggregation of DNA-linked 13 nm gold
particles in comparison to that measured for unmodified DNA
was reported previously and explained by the higher DNA
density on the particles.37 The sharp transition observed here
can be explained by the effect of multiple connections between
the vesicles (combinatorial entropic factors38,39) and a reduction
of local salt concentration upon partial dehybridization.37,40
In more detail, only at the contact sites of vesicles the distance
Table 1 Sequences of the oligonucleotides used. TMR is tetramethylrho-
damine and L is the a-tocopherol anchor
Name Sequence
TL(dT)18L(dT)5 50-TLT TTT TTT TTT TTT TTT TTL TTT TT-30
(dA)20 50-AAA AAA AAA AAA AAA AAA AA-30
(dT)20 50-TTT TTT TTT TTT TTT TTT TT-30
30Rh(dA)20 50-AAA AAA AAA AAA AAA AAA AA_TMR-30
30Rh(dT)20 50-TTT TTT TTT TTT TTT TTT TT_TMR-30
Fig. 1 Fluorescence microscopy images of the POPC/N-NBD-DPPE vesicle
aggregates, 400 mM total lipid, induced by the hybridization of LiNA with
30Rh(dA)20, 200 nM each. (A) N-NBD, (B) rhodamine fluorescence images of
the same area, respectively. Scale bars correspond to 10 mM.
Fig. 2 Determination of the transition temperatures of (A) melting of the
LiNA/(dA)20 hybrid, 480 nM, absorption at 270 nm; and (B) disassembly of
the LiNA/(dA)20 hybridization-induced vesicle aggregates, 400 mM POPC
LUVs; light scattering at 600 nm. The width of the transition is B10 and
2.3 1C, respectively. Red lines are the linear fits of the initial, middle, and
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between vesicle membranes is small enough to enable the insertion
of the two a-tocopherol anchors of a LiNA/(dA)20 hybrid into the
hydrophobic environment of the two opposing membranes. Outside
the contact sites only one hydrophobic anchor of the stiff hybrid
could insert into a membrane while the other would be exposed
to the aqueous phase being energetically unfavorable. Hence,
contact sites ensemble a trap enriching the hybrids locally. As a
consequence, when raising temperature apparently cooperative
dehybridization will occur caused by a change of DNA length and
a reduction of local salt concentration upon partial dehybridiza-
tion. The steep and sharp transition of vesicle disaggregation is
in agreement with previous reports.11,40,41
Aggregation of the vesicles upon hybridization with an
unlabeled complement was then measured by 901 light scattering
(Fig. S2 and S3, ESI†) and UV absorption (Fig. 3A). We studied the
dependence of the aggregation kinetics on the lipid concentration
and observed that the rate of the aggregation increased with the
increasing concentration (Fig. 3A). Therefore, not only the amount
of DNA per vesicle,17 but also the lipid concentration is crucial for
the rate of the aggregation of the model vesicles. The initial rates
were proportional to the ratio of the concentrations and lowest
tested concentration c0 by the power of b = 2.2  0.2 as shown in
Fig. 3B. The second-order kinetics indicates that collision of two
vesicles might be the rate limiting step for the initial aggregation
(see ESI† for details).
Finally, based on the properties of the LiNA reported here,
we suggest that a LiNA may act as a synthetic structure
mimicking the function of tetherin which has membrane
anchors at both N and C-termini and was shown to tether
budding HIV viruses to the surface of the infected cells.25–27 To
this end, we investigated whether the LiNA hybridization can
induce aggregation of HIV virus-like particles (VLPs).35,42 VLPs
are of 100–120 nm diameter and resemble native-like virions.
Gag protein is required for the VLP formation; VLPs used here
contained a fusion protein of Gag with YFP or mCherry.
We observed that addition of (dA)20 to VLPs pre-incubated
with the LiNA led to an increase in light scattering (Fig. 4A).
The scattering experiments required 1 mL sample volume for
stirring, therefore, only a very low concentration of VLPs could
be used. The increase in scattering is rather low, nevertheless, it
is comparable with the increase in scattering for the similarly
low concentration of lipid vesicles (see Fig. 3A, 55 mM). Using
higher VLP concentrations (in a smaller volume), aggregates
were also detected using a microscope 10 min after addition of
the complement to VLPs pre-incubated with LiNA for 30 min
(Fig. 4B and C). The results show that tocopherol anchors could
easily insert into the lipid envelope of the VLPs and cause
aggregation due to DNA-hybridization and accompanied exposure
of hydrophobic anchors as described above for model vesicles.
Indeed this VLP aggregation is reminiscent of the chain-like
aggregation of HIV viruses attached on the cell surface observed
by electron microscopy.27
While the density of spike proteins in the HIV envelope is
rather low, other enveloped viruses have a very high density of
spike proteins, e.g. hemagglutinin, the major surface protein of
the Influenza viruses, covers more than 80% of the surface and
is at least 13 nm high.43,44 To trigger aggregation of such
viruses it may require longer DNA-strands as used here. This
conclusion is supported by a recent report of Selden et al.45 who
showed that a long linker of at least 60 nucleic bases was
necessary for cell–cell attachment. Recently, cholesterol-modified
PEG presented on a glass surface via biotin/avidin was used to
immobilize lipid vesicles, viruses, bacteria, and yeast cells.46 Hence,
also for a controlled and more efficient virus aggregation, a longer
lipophilic nucleic acid with a longer sequence or a linker might be
required.
Lipophilic nucleic acids modified with two palmitoyl chains
or cholesterol partitioning into raft domains specifically were
recently reported by us and others.10,47–49 Application of different
lipophilic anchors allows sequestration of the LiNAs in domains
and a remote control of the functional moieties by temperature48 or
enzymatic cleavage.49 As tetherin was found to localize in rafts,50 a
similarly built LiNA with a longer sequence and two anchors
partitioning into raft-like domains, e.g. cholesterol or palmitoyl
anchors, might even better mimic tetherin.
Taken together, we have shown here that aggregation of HIV
virus-like particles, likewise to the aggregation of lipid vesicles,
can be achieved using the lipophilic nucleic acid with two
lipophilic anchors each close to one end of the sequence.
Fig. 3 POPC DNA-hybridization induced vesicle aggregation depends on
lipid/vesicle concentration. (A) POPC vesicles were pre-incubated with
200 nM LiNA. Addition of (dA)20 at time 0 s induced aggregation and,
therefore, increase in turbidity of the sample measured at 400 nm. The
rate and the intensity of the signal increased with increasing lipid concen-
tration as shown for 0, 55, 90, 150, 170, 270, 450, and 540 mM lipid.
(B) Second order dependence of the initial rate on the ratio of the lipid
concentrations c/c0, where c0 = 55 mM. Squares are data points from two
independent experiments. Lines are the fitting curves f (x) = axb with
b = 2.2  0.2.
Fig. 4 Addition of LiNA and (dA)20 to virus-like particles (VLPs) causes
particle aggregation. (A) Light scattering at 310 nm upon addition of the
LiNA at 260 s and (dA)20 at 510 s (black curve) or upon addition of (dA)20 at
500 s (red curve) to 15 mL VLPs in 1 mL buffer, 37 1C; Fluorescence
microscopy images of VLPs (5 mL VLPs in 50 mL buffer) pre-incubated with
the LiNA, 200 nM for 30 min: before (B) and 10 min after addition of (dA)20,
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Experimental
The sequence of the addition of the oligonucleotides was not
essential for the aggregation process (Fig. S2, ESI†); however,
the initial aggregation rates were slightly higher when vesicles
were pre-incubated with the LiNA. HIV virus like particles
labeled with mCherry or YFP were isolated as described else-
where42 and were a kind gift of Andrea Gramatica. For details of
VLPs see ESI.† Total protein concentration of the VLP stocks
was about 0.8 mM.
This work was supported by the grants of the Deutsche
Forschungsgemeinschaft (AR 783/1-1 (AA); SFB 765 (AH)), the
Federal Ministry of Education and Research (BMBF INUNA
0312027 (JL, AH)), and the Humboldt University Gender Equal
Opportunities Fund (52516/0105 (AA)). We are grateful to
Andrea Gramatica for providing the virus-like particles.
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